Trial of Modafinil to Improve Neurocognitive Deficits in Children Treated for a Primary Brain Tumor
Clinical Trial
Offered by: ¾Ã¾Ã¾Ã¾Ã¾Ã¾Ã¾Ã¾«Æ· Children's Health, Jacksonville
Location: Jacksonville, Fla.
Trial Name
SCUSF 0901 Phase II Placebo-Controlled Trial of Modafinil to Improve Neurocognitive Deficits in Children Treated for a Primary Brain Tumor
Ìý
What is the trial about?
To compare the effects of Modafinil given to children with neurocognitive changes following treatment for brain cancer.
Who can participate?
Age ≥6 years and ≤17 years 10 months at the time of study entry.
What is involved?
Length of study is 10 weeks. Includes neurocognitive tests and physical exam.
Is a Clinical Trial Right for Your Child?
Learn more about clinical trials and get answers to questions you might have.
